Assenagon Asset Management S.A.

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1546007 SENNINGERBERG, N4

Position in FDMT

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$1,108,328

+$332,498 QoQ

Shares Held

83,333

0.0% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#53

of 158 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. FDMT ranks #49 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	759,564	$377,298,225
2	ROIV	Roivant Sciences Ltd.	8,362,952	$295,964,871
3	REGN	Regeneron Pharmaceuticals, Inc.	244,927	$152,721,781
4	AXSM	Axsome Therapeutics, Inc.	454,682	$111,292,513
5	BMRN	Biomarin Pharmaceutical Inc	1,762,086	$100,826,560
6	HALO	Halozyme Therapeutics, Inc.	997,643	$78,085,517
7	MDGL	Madrigal Pharmaceuticals, Inc.	124,214	$66,696,707
8	TARS	Tarsus Pharmaceuticals, Inc.	947,495	$59,635,335

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,108,328	83,333	0.0%	Shares	Sole	2026-07-08
2026-03-31	$775,830	83,333	-71.9%	Shares	Sole	2026-04-20
2025-12-31	$2,221,492	296,199	-55.4%	Shares	Sole	2026-01-09
2025-09-30	$5,767,179	663,657	+2.3%	Shares	Sole	2025-10-07
2025-06-30	$2,407,140	648,825	-0.3%	Shares	Sole	2025-07-11
2025-03-31	$2,102,587	650,956	-0.4%	Shares	Sole	2025-04-15
2024-12-31	$3,640,162	653,530	-57.7%	Shares	Sole	2025-01-14
2024-09-30	$16,684,305	1,543,414	+238.3%	Shares	Sole	2024-10-23
2024-06-30	$9,577,044	456,267	+6.0%	Shares	Sole	2024-07-18
2024-03-31	$13,717,514	430,556	—	Shares	Sole	2024-04-24
No filing history on record for this holder in this stock.